stock price decline

ImmunityBio shares plunge 21% after FDA warning over unsupported cancer treatment claims, erasing $2 billion in market value and triggering securities litigation.

Disc Medicine ($IRON) stock fell 22% after FDA rejected bitopertin program, triggering class action lawsuit investigation by Rosen Law Firm.

Beyond Meat's stock has collapsed 84% from its 52-week high, falling below Nasdaq's $1 minimum threshold and forcing the company to consider a reverse stock split to maintain listing compliance.

TruBridge restates three years of financials due to material errors in revenue recognition, stock-based compensation, and software capitalization. Stock fell 10.5%.

The Portnoy Law Firm investigates $TNDM after a 19.9% stock plunge triggered by insulin pump malfunction disclosures that could halt insulin delivery.

Kirby McInerney files class action against Power Solutions International for allegedly overstating data center demand and understating manufacturing costs, citing margin deterioration.

Johnson Fistel investigates Lumexa Imaging Holdings for potential securities fraud following March 2026 disclosures that triggered significant stock declines. Affected investors are encouraged to contact the firm about recovery options.

Trip.com investors can file claims by May 11, 2026, in lawsuit alleging the company concealed Chinese antitrust investigation and monopolistic practice risks.

Portnoy Law Firm launches class action against $SMCI over alleged unlicensed server exports to China. Stock plunges 33% after DOJ indictment of three individuals.

Law firm Robbins LLP urges $PSIX investors to act by May 19, 2026 deadline in class action alleging misleading data center projections and hidden manufacturing issues.

Corcept Therapeutics shares crashed 50% after FDA rejected relacorilant application. Class action lawsuit alleges company concealed prior FDA warnings about clinical development concerns.

Trip.com faces securities fraud lawsuit over concealed antitrust investigation. Stock fell 17% when probe was disclosed.

ODDITY Tech stock crashes 49% after disclosing algorithm changes by major ad partner will slash Q1 revenue 30%. Securities fraud lawsuit filed by shareholders.

Portnoy Law Firm launches securities fraud investigation into Abacus Global over alleged inflated life expectancy data. Stock drops 21.5% to $6.00 per share.

Law firm investigates JFrog for possible securities fraud after 27.5% stock decline triggered by slashed guidance and weak cloud revenue growth.

Portnoy Law Firm files class action against $SNOW for allegedly concealing product efficiency impacts on revenue. Stock fell 18% after February 2024 disclosure.

Portnoy Law Firm sues Apollo Global Management over undisclosed Epstein communications, citing material misrepresentations to investors during 2021-2026 period; stock fell 5-6% post-disclosure.

Driven Brands faces class action lawsuit after restating 2023-2025 financials; stock fell 40%. Investors with $100K+ losses must file lead plaintiff claims by May 8, 2026.

Kyndryl faces securities class action lawsuits after disclosing material control weaknesses and executive departures. Stock fell 55% to $10.59; lead plaintiff deadline set for April 13, 2026.

uniQure faces securities lawsuit after FDA rejected AMT-130 drug candidate data adequacy. Stock plunged 49% following disclosure. Lead plaintiff deadline April 13, 2026.